Multiple sclerosis

Multiple sclerosis

• Higher prices for MS drug help drug firm Merck

  Higher prices for its multiple sclerosis drug Rebif helped German pharmaceutical and high-tech materials company Merck KGaA post a 54 percent rise in ... 

• 

  Irish court: No 'right to die' for paralyzed woman

  A paralyzed Irish woman who wants to die cannot legally commit suicide with her partner's help, Ireland's Supreme Court ruled Monday in a case that ... 

• Correction: FDA-Multiple Sclerosis Drug story

  In a story March 27 about a new multiple sclerosis drug, The Associated Press reported erroneously that Novartis' drug Gilenya was launched in March ... 

• Elan moves to deter takeover bid

  Irish drug maker Elan Corp. announced Monday it will pay shareholders a recurring special dividend linked to the sales of the multiple sclerosis ... 

• Elan, Biogen change terms of Tysabri collaboration

  Biogen Idec will take over full ownership of the multiple sclerosis treatment Tysabri from its partner Irish drugmaker Elan Corp. PLC in exchange for ...